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ABSTRACT
OBJECTIVE: To analyze the prevalence and associated factors regarding the use of medicines 
by self-medication in Brazil.
METHODS: This cross-sectional population-based study was conducted using data from the 
PNAUM (National Survey on Access, Use and Promotion of Rational Use of Medicines), collected 
between September 2013 and February 2014 by interviews at the homes of the respondents. All 
people who reported using any medicines not prescribed by a doctor or dentist were classified as 
self-medication practitioners. Crude and adjusted prevalence ratios (Poisson regression) and their 
respective 95% confidence intervals were calculated in order to investigate the factors associated 
with the use of self-medication by medicines. The independent variables were: sociodemographic 
characteristics, health conditions and access to and use of health services. In addition, the most 
commonly consumed medicines by self-medication were individually identified. 
RESULTS: The self-medication prevalence in Brazil was 16.1% (95%CI 15.0–17.5), with it 
being highest in the Northeast region (23.8%; 95%CI 21.6–26.2). Following the adjusted 
analysis, self-medication was observed to be associated with females, inhabitants from the 
North, Northeast and Midwest regions and individuals that have had one, or two or more 
chronic diseases. Analgesics and muscle relaxants were the therapeutic groups most used for 
self-medication, with dipyrone being the most consumed medicines. In general, most of the 
medicines used for self-medication were classified as non-prescriptive (65.5%).
CONCLUSIONS: Self-medication is common practice in Brazil and mainly involves the use of 
non-prescription medicines; therefore, the users of such should be made aware of the possible 
risks.
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INTRODUCTION
Medications are important social goods that are heavily used by the Brazilian 
population4. The use of these drugs is influenced by various factors. Some of these 
factors are in relation to the Brazilian population’s increase in life expectancy, the 
consequent growing frequency of chronic disease, the emergence of new and old 
transmittable diseases, the increasing prevalence of mood disorders, diseases arising 
from environmental degradation, environmental pollution and climate change, and 
the growing financial investment made by the Brazilian government to ensure access 
to health care services for all17. 
There are still difficulties regarding access, delay and low quality of care in health services, 
both in the public and private sectors, all of which exist despite the advances made. 
In addition to these aspects, the marketing of non-prescription drugs in the media, the 
existence of home-stored medication and the belief that drugs solve all health problems, 
are important factors involving self-medication16.
The World Health Organizationa (1998) defines self-medication as the selection 
and use of non-prescription drugs without supervision from a physician or dentist. 
Self-medication is a worldwide phenomenon, the prevalence of such can differ depending 
on the population studied, the method and the recall period employed: in Germany9, the 
prevalence for medication use on a self-medication basis was 27.7%; in Portugal14, this 
was 26.2%; in Spain7, 12.7%; in Cuba8, 7.3%; in Athens-Greece2, 23.4%; in the Catalonia 
region of Spain20, 34.0% among men and 25.0% among women; and in Pondicherry-India22, 
this was equal to 11.9%.
There have been few population-based studies in Brazil to have investigated the 
pattern of medication consumption for the Brazilian population as a whole5,6. A study 
performed by Carvalho et al.4 (2005) showed that overall prevalence of medication use 
by the section of the population older than 18 years, 15 days before interview, was 49.0% 
and 24.6% for self-medication. Other studies focus on the populations from Brazilian 
municipalities. The prevalence of self-medication ranged from 27.0% and 32.0% among 
residents, aged over 40 years21, from the city of Sao Paulo (Sao Paulo state); whereas the 
prevalence of exclusive consumption of non-prescription drugs was 28.8% in Bambui, 
MG, Southeastern Brazil, a result found during a study with people aged 18 years or 
over12. In Santa Maria, RS, Southern Brazil, 76.1% of the interviewed individuals claimed 
to have self-medicated at least once24.
In this context, considering the small number of published studies that have a national 
representation, the PNAUM (National Survey on Access, Use and Promotion of Rational Use 
of Medicines), developed by the Brazilian Ministry of Health, makes it possible to evaluate 
the self-medication situation in Brazil as a relevant theme, given the inherent risks to its 
practice (medicinal poisoning and adverse reactions) and the possible increase in health 
care spending13,18,19.
Therefore, the objective of this study was to analyze the prevalence and factors associated 
with the use of drugs by self-medication in Brazil.
METHODS
Data from PNAUM were used in this population-based cross-sectional study. The survey 
was conducted in Brazil, between September 2013 and February 2014 using probabilistic 
samples randomly drawn from eight demographic aspects according to age group and 
gender, the individuals involved in the study were residing in the urban areas from each 
Brazilian region, including the capitals, with sampling by conglomerates in three stages. 
During the first stage, the municipalities were drawn (n = 60 per region); the second, the 
a World Health Organization. The 
role of the pharmacist in self-care 
and self-medication. Report of 
the 4th WHO Consultive Group 
on the role of the pharmacist. 
The Hague: World Health 
Organization; 1998.
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census sectors (two in each municipality); and the third, the households. 41,433 individuals 
were interviewed in total. Further information regarding the sampling plan and the size of 
the sample are described in PNAUM’s methodological article15. 
The structured questionnaire was created and tested beforehand by a team of researchers 
from PNAUM. The interviews were conducted in the selected households by trained 
researchers, who used electronic equipment (tablets) in order to collect the data.
Information relating to those below 15 years of age and the disabled were provided by their 
legal guardians (proxies). The questionnaire was modified for this population subgroup, 
with some blocks of questions that required the respondent’s judgment being excluded (see 
methodological article15).
The outcome of the study is the use of drugs for self-medication. Information regarding 
medication consumption was obtained in three ways: first, with direct questions related 
to the use of medicines that had been medically indicated to treat highly prevalent 
chronic diseases (hypertension; diabetes; heart disease; high cholesterol; stroke; chronic 
lung disease; arthritis, osteoarthritis or rheumatism; depression) and other diseases that 
had lasted more than six months at the time of the interview. The second, by a question 
regarding the use of any medications to treat acute diseases (infection; medicine for sleep 
or to control nervous conditions; stomach or intestinal problems; fever; pain; influenza; 
cold or allergic rhinitis; for nausea and vomiting or other acute problem), during the 
15 days prior to the interview. The third was in regards to the use of contraceptives (oral 
and injectable), at the time of the interview. In the second and third methods involved 
asking who recommended the medicine (doctor or dentist; nurse; pharmacist; another 
health professional; self-employed; relative, friend or neighbor; spouse or common law 
partner; partner or boyfriend/girlfriend; pharmacy clerk; other). Thus, all those who 
reported consuming at least one medication without medical or dentist prescription, 
during the 15 days prior to the interview, including contraceptives, were classified as 
self-medicating practitioners.
The interviewers asked all the respondents to submit to them the drugs that they continually 
used or those they used in the previous 15 days, at the time of the interview. The medicines 
were classified according to the Anatomical Therapeutic Chemical Classification System, 
namely the ATC classification system (level 1, organs or systems; level 2, therapeutic subgroup; 
level 5, drug)25 and, according to the legal category, in non-prescription drugs (NPD)b, for 
sale under prescription and medicine controlledc.
The exploratory variables were as follows: sociodemographic characteristics, descriptors 
for health condition, access and use of health services. The sociodemographic variables 
were: gender ; age in years; skin color (white, black, yellow, brown, indigenous); Region 
of Brazil (North, Northeast, Midwest, South, Southeast); Education in years (0-8 years, 
9-11, 12 or more); economic classification (A/B, C, D/E), according to Brazilian 
Economic Classification Criterion of the Brazilian Association of Research Companies 
(CCEB 2013/ABEP – http://www.abep.org). The descriptors for health condition 
were: number of chronic illnesses as reported by the individual (none; one; two or 
more). The descriptor for access to health services was: health insurance (yes; no). 
The descriptor for use of health services was: hospitalization in the 12 months prior 
to the interview (yes; no). This study resulted in a distribution being found regarding 
the prevalence of self-medication in Brazil’s five regions, which were according to the 
sociodemographic aspects.
An exploratory descriptive analysis was conducted on all the variables involved in the 
study and a presentation of the relative frequencies and their respective 95% confidence 
intervals (95%CI). The Poisson regression model was used to estimate the crude and 
adjusted prevalence ratios (PR), and the 95%CI. These analyses were conducted with Stata 
version 12 statistical software, using the set of svy commands designed to analyze complex 
b Ministério da Saúde. Agência 
Nacional de Vigilância Sanitária. 
Resolução RDC nº 138, de 29 de 
maio de 2003. Dispõe sobre o 
enquadramento na categoria de 
venda de medicamentos. Diario 
Oficial Uniao. 6 jan 2004.
c Ministério da Saúde. Secretaria 
Nacional de Vigilância Sanitária. 
Portaria nº 344, de 12 de maio 
de 1998. Aprova o regulamento 
técnico sobre substâncias 
e medicamentos sujeitos a 
controle especial. Diario Oficial 
Uniao. 1 fev 1999.
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samples and ensure the necessary weighting, with the sampling design being a matter for 
consideration. Variables with p < 0.20 were included in multiple model and a significance level 
of 5% was adopted to maintain the variables in the model, along with backward selection of 
the variables. The statistical significance of the prevalence ratios obtained from the Poisson 
regression models was evaluated using the Wald test.
Variable Prevalence (%)a 95%CI p
Gender < 0.001
Female 19.0 17.4–20.5
Male 13.1 11.7–14.6
Age group (years) < 0.001
0-9 6.6 5.5–8.0
10-19 12.6 10.7–14.7
20-39 21.6 19.6–23.7
40-59 17.7 16.2–19.4
≥ 60 14.3 12.9–15.8
Color < 0.001
White 15.4 14.1–16.9
Black 18.4 16.0–21.0
Yellow 25.2 19.1–32.6
Brown 17.2 15.5–19.1
Indigenous 29.8 17.6–45.7
Education (years) < 0.001 
0-8 14.7 13.4–16.0
9-11 19.0 17.1–21.0
≥ 12 19.4 16.8–22.3
Economic classificationb 0.866
A/B 16.3 14.4–18.5
C 16.3 14.8–17.8
D/E 15.8 14.1–17.7
Region < 0.001
North 17.8 15.0–21.0
Northeast 23.8 21.6–26.2
Southeast 12.8 10.9–14.9
South 11.4 10.1–12.9
Midwest 19.2 17.3–21.3
No. chronic diseases < 0.001
0 14.6 13.3–15.9
1 18.8 16.8–21.1
2 + 20.4 18.6–22.3
Health insurance 0.709
Yes 16.5 14.5–18.7
No 16.1 14.7–17.5
Hospitalized in the previous year < 0.001
Yes 20.6 18.2–23.3
No 16.0 14.7–17.3
Total 16.7 15.4–18.0
Table 1. Prevalence for the use of at least one drug by self-medication, according to demographic, 
socioeconomic aspects, health conditions indicators and access to health services indicators. PNAUM, 
Brazil, 2014. (N = 40,833)
a Percentages adjusted for sample weights and post-stratified according to age and gender.
b The Economic Classification variable is according to the 2013 Brazilian Economic Classification Criterion of the 
Brazilian Association of Research Companies (www.abep.org).
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This study was conducted in accordance with the recommendations set out in the 
Declaration of Helsinki and Brazilian Legislation for Ethics in Research. The study was 
approved by the Brazilian National Commission for Ethics in Research (Protocol 398,131, 
of 16 September, 2013).
RESULTS 
Six hundred of the 41,433 people interviewed were excluded for not providing information 
regarding who recommended the drug they were using.
The prevalence of self-medication in the Brazilian population was 16.1% (95%CI 15.0–17.5); 
the prevalence was higher in female individuals, those aged between 20-39 years, among 
individuals who declared themselves to be of indigenous and yellow skin color, with time 
spent in education equal to or greater than 12 years, residents of the Northeast region, 
between the one and two or more chronic illnesses and those who were hospitalized one 
or more times in the last year (Table 1).
In regards to the distribution of self-medication prevalence, according to the sociodemographic 
aspects, based on the five regions in Brazil (Table 2), women and people in the 20 to 39 years 
age group consumed a larger quantity of self-medication drugs in all regions of the country, 
when compared with men. In both situations, the highest prevalences were in the Northeast 
and the Midwest regions. The prevalence increased gradually from the 0-9 years to the 
20-39 years age group, and subsequently declined in all the regions. The prevalence also 
increased along with time spent in education and with better socioeconomic level, the 
exception being the North region.
Variable
Self-medication prevalence
North Northeast Southeast South Midwest
% 95%CI % 95%CI % 95%CI % 95%CI % 95%CI
Gender
Female 19.2 15.9–23.0 27.5 25.1–30.0 15.3 13.0–18.0 13.1 11.6–14.8 22.9 20.3–25.6
Male 16.3 13.4–19.6 19.6 16.9–22.6 9.9 7.8–12.4 9.5 8.1–11.2 15.5 13.1–18.4
Age group (years)
0-9 10.9 8.1–14.5 11.9 9.2–15.2 2.5 1.4–4.3 3.6 2.3–5.6 8.7 6.5–11.5
10-19 15.5 10.8–21.7 19.6 15.6–24.3 9.3 6.7–12.8 5.6 3.7–8.2 17.0 12.6–22.7
20-39 23.1 19.5–27.0 31.2 27.5–35.2 17.4 14.4–20.9 15.1 12.8–17.8 24.3 20.9–28.0
40-59 18.9 15.4–22.9 25.6 23.1–28.3 14.8 12.3–17.7 14.8 12.0–15.8 20.0 17.7–22.5
≥ 50 14.3 11.9–17.1 21.4 18.8–24.2 11.3 9.3–13.7 11.9 10.0–14.1 19.6 16.9–22.6
Education (years)
0-8 17.3 14.3–20.7 21.8 19.6–24.3 11.0 9.2–13.0 10.5 9.1–12.1 18.0 15.8–20.5
9-11 19.9 16.1–24.3 29.4 23.7–31.4 16.0 13.2–19.4 13.1 11.0–15.6 20.5 17.9–23.3
≥ 12 years 16.1 10.9–23.2 32.9 28.1–38.2 16.1 12.1–21.0 13.5 10.4–17.4 22.7 18.2–28.0
Economic classificationb
A/B 17.7 13.1–23.5 26.6 20.8–32.6 15.0 12.1–18.6 12.2 10.3–14.4 20.5 17.2–24.3
C 18.8 15.6–22.5 24.5 21.9–27.4 12.6 10.5–15.0 11.3 9.7–13.1 19.0 17.0–21.2
D/E 15.7 12.5–19.6 22.2 19.7–24.9 10.1 7.7–13.1 10.1 7.5–13.7 18.0 14.5–22.0
Table 2. Prevalence for the use of at least one drug by self-medication, according to demographic and socioeconomic aspects by geographic 
region. PNAUM, Brazil, 2014a. (N = 40,833)
a Percentages adjusted for sample weights and post-stratified according to age and gender.
b According to the 2013 Brazilian Economic Classification Criterion of the Brazilian Association of Research Companies (www.abep.org).
6s
Self-medication in Brazil Arrais PSD et al.
DOI:10.1590/S1518-8787.2016050006117
During the multivariate analysis (Table 3), the consumption of drugs by self-medication 
showed a positive association for the female gender (PR 1.33; 95%CI 1.21–1.47), the 10 
to 19 years (PR 2.03; 95%CI 1.66–2.47), 20 to 39 years (PR 3.46; 95%CI 2.94–4.08), 40 to 
59 years (PR 2.68; 95%CI 2.26–3.17) and 60 or more years (PR 1.95; 95%CI 1.63–2.34) age 
groups, those residing in the North (PR 1.76; 95%CI 1.44–2.16), Northeast (PR 2.33; 95%CI 
2.00–2.72) and Midwest (PR 1.74; 95%CI 1.49–2.04) regions, and those that have one (PR 
1.17; 95%CI 1.06–1.29) and two or more chronic diseases (PR 1.33; 95%CI 1.18–1.50). 
Variable Crude PR 95%CI p Adjusted PR 95%CI p
Gender < 0.001 < 0.001
Male 1 1
Female 1.44 1.31–1.59 1.33 1.21–1.47
Age group (years) < 0.001 < 0.001
0-9 1 1
10-19 1.89 1.54–2.33 2.03 1.66–2.47
20-39 3.25 2.72–3.89 3.46 2.94–4.08
40-59 2.68 2.22–3.21 2.68 2.26–3.17
≥ 60 2.15 1.78–2.59 1.95 1.63–2.34
Color < 0.001 0.045
White 1 1
Black 1.19 1.04–1.37 0.93 0.81–1.07
Yellow 1.63 1.25–2.13 1.11 0.88–1.40
Brown 1.11 1.00–1.23 0.90 0.82–1.00
Indigenous 1.93 1.18–3.16 1.37 0.89–2.12
Education (years) < 0.001
0-8 1
9-11 1.37 1.17–1.43
≥ 12 1.37 1.15–1.52
Economic classification* 0.858
D/E 1
A/B 1.03 0.90–1.20
C 1.03 0.93–1.13
Region < 0.001 0.001
North 1.56 1.27–1.92 1.76 1.44–2.16
Northeast 2.10 1.79–2.44 2.33 2.00–2.72
Southeast 1.12 0.92–1.36 1.18 0.97–1.42
South 1 1
Midwest 1.18 1.44–1.98 1.74 1.49–2.04
No. chronic diseases < 0.001 < 0.001
0 1 1
1 1.33 1.20–1.48 1.17 1.06–1.29
≥ 2 1.33 1.20–1.47 1.33 1.18–1.50
Health insurance 0.708
No 1
Yes 1.03 0.90–1.18
Hospitalized in the previous year < 0.001
No 1
Yes 1.29 1.14–1.47
* According to the 2013 Brazilian Economic Classification Criterion of the Brazilian Association of Research 
Companies (www.abep.org).
Table 3. Crude and adjusted prevalence ratios or the use of at least one drug by self-medication, 
according to demographic, socioeconomic aspects, health conditions indicators and access to health 
services indicators. PNAUM, Brazil, 2014. (N = 40,833)
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The respondents reported using 57,424 different kinds of drugs, 8,545 of which (17.0%) were 
characterized as being a self-medication type. It was not possible to identify the source of 
who recommended 3,258 medicines, these were therefore considered losses. 
The drugs most commonly consumed, according to the first level from the ATC 
classification were those used for central nervous system (34.3%), followed by products 
used for the musculoskeletal apparatus, digestive tract and metabolism, respiratory 
system, genitourinary system and sex hormones, anti-infective for systemic use and others. 
In regards to the distribution of drugs by therapeutic group from the ATC classification 
(second level), the most frequent were: analgesics (33.4%; 95%CI 31.4–35.4), followed by 
the muscle relaxants and anti-inflammatory or antirheumatic agents, totaling 58.9% of 
medications consumed (Table 4). 
The drugs most frequently consumed by self-medication (Table 5) were: dipyrone, single 
fixed-dose caffeine-orphenadrine-dipyrone and paracetamol. Most of the medications were 
generally classified as non-prescription drugs (65.5%), followed by the sale of prescription 
medication (24.4%) and the special control drugs (0.5%) (Table 5). 48.5% of the 12 most used 
drugs (self-medication) were non-prescription drugs. 
Therapeutic subgroup % 95%CI
Analgesics 33.4 31.4–35.4
Muscle relaxers 14.8 12.5–15.3
Anti-inflammatories and antirheumatics 11.7 10.4–13.2
Cough and cold remedies 5.9 5.0–6.9
Supplements (general nutrients) 3.9 3.3–4.6
Drugs for acid-imbalance-related disorders 3.8 3.3–4.6
Sex hormones and genital system modulators 3.1 2.5–3.7
Drugs for functional gastrointestinal disorders 2.8 2.3–3.3
Plants 2.7 2.2–3.4
Vitamins 2.4 1.8–3.1
Antibacterials for systemic use 2.3 1.9–2.8
Other 14.3 13.1–15.6
Total 100
Table 4. Distribution of drugs used in self-medication, according to the ATC classification (2nd level). 
PNAUM, Brazil, 2014. (N = 8,545)
Drug % 95%CI NPDb PDc
Dipyrone 15.4 13.9–17.1 X
Caffeine + orphenadrine + dipyrone 12.1 10.8–13.6 X
Paracetamol 11.4 10.2–12.8 X
Caffeine + carisoprodol + diclofenac + paracetamol 3.6 3.0–4.4 X
Diclofenac 3.5 2.7–4.5 X
Caffeine + dipyrone + isometheptene 3.3 2.5–4.2 X
Ethinylestradiol + levonorgestrel 2.5 2.0–3.0 X
Ibuprofen 2.3 1.8–3.0 X
Phenylephrine + chlorpheniramine + paracetamol 2.2 1.6–2.9 X
Omeprazole 1.8 1.4–2.4 X
Caffeine + chlorpheniramine + dipyrone 1.8 1.4–2.5 X
Nimesulide 1.6 1.2–2.1 X
Table 5. Distribution of the 12 most commonly used drugs by self-medication, according to the ATC 
classification (5th level) and legal category. PNAUM, Brazil, 2014a. (N = 8,545)
a Corresponds to 61.4% of the drugs used for self-medication.
b Non-Prescription Drug.
c Medication for sale with prescription or single-use prescription (red + black stripe).
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DISCUSSION 
The prevalence of self-medication in Brazil was lower than that found by Carvalho et al.4 
(2005), in a study in Brazil, and by Knopf and Grams9 (2013), in Germany. However, the 
prevalence was greater than that found in Sri Lanka26, Cuba8, and Spain7. We found variations 
in five Brazilian regions – the Northeast, Midwest and North, in which prevalences greater 
than the national prevalence were found. 
Brazil is currently undergoing many transformations in healthcare, in which financial and 
infrastructure investment have been observed aimed at increasing the supply of health 
services, mainly in the area of primary care, with the Brazilian Family Health Strategy, and 
in the area of pharmaceutical care to ensure free access and rational use of medicines by 
professionals, and the community in general17,23. These transformations happen in different 
ways among the regions, however, despite the regional inequalities being exposed, greater 
access to medical services may promote less self-medication. Self-medication can also be 
considered to be within an acceptable range of magnitudea, because, as was noted during 
this study, the use of drugs for self-medication is restricted to self-limited acute diseases, 
such as stomach or intestinal problems, fever, pain, flu, colds or allergic rhinitis, nausea 
and vomiting, among others, and mostly to non-prescription products (65.5%). This result 
is in line with the results from a study performed in Brazil by Ahmed et al.1 (1997), in which 
the painful symptoms accounted for 24.3% of the motivations behind people practicing 
self-medication, with viral or infectious problems (high respiratory infection and diarrhea) 
accounting for 21.0%. Headache was found to be the main complaint for self-medication, 
followed by respiratory and digestive symptoms, during a study by Vilarino et al.24 A study 
by Carrera-Lasfuentes et al.3 found that pain was the most reported complaint.
No significant association was found between the practice of self-medication and economic 
classification. This result can be explained by the fact that the most frequently consumed 
drugs are of low cost, easy access and are most frequently prescribed4,5, including those free of 
charge medications made available from the Brazilian Unified Health System, such as those 
subsidized by the Farmácia Popular (Popular Pharmacy Program) (as is true for dipyrone, 
acetaminophen, and ibuprofen). 
The finding that self-medication is most practiced by female individuals has also been found 
in other publications2,4,9, despite national and11 international3,8,14,22,26 studies indicating that 
self-medication is more prevalent among men. The results of this study may have influenced 
by the fact that women suffer more with headaches, muscle pain and chronic pain conditions, 
such as migraine, and use painkillers and muscle relaxers from an early age for pain relief 
during menstruation or dysmenorrhoea2,19. 
Self-medication was also associated with the various age groups from the study, with the 
most prevalent users being between the ages of 20 and 39 years. This result can generally 
be attributed to health problem types that involve self-limited acute diseases, common to 
all ages, and the kind of medication consumed, with analgesics being the main therapeutic 
group used in the practice of self-medication4,6,8,9,11,14,20-22,24, irrespective of target population 
investigated and recall period. 
This fact could also explain the positive association between the practice of self-medication 
with the various regions in Brazil and among individuals with chronic diseases or conditions, 
since analgesic/antipyretic medications are generally the second most used drug in Brazil 
and in the five regions of the country, second only to the antihypertensive drugs5.
In the case of the association of self-medication with age and the presence of chronic diseases, 
the results of this study differ from those found in Bambui, Minas Gerais12, where a negative 
association was found for age and self-medication showed no association with a history of 
disease or selected chronic conditions. This fact may be explained by the difference concerning 
when the research was conducted, since the emergence of new and old infectious diseases 
such as dengue fever, zika and chikungunya, the increasing prevalence of diseases arising from 
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environmental degradation, environmental pollution and climate change17 may have intensified 
the appearance of self-limited acute diseases that encourage the practice of self-medication. 
The most frequently consumed drugs were dipyrone, single fixed-dose dipyrone, orphenadrine 
and caffeine, and paracetamol. Similar data were found in national1,24 and international8,11 
studies. These drugs are generally found in household medical supplies10 and are normally 
used to relieve signs and symptoms or acute11,12, minor or self-limited complaints. 
The elevated use of painkillers for self-medication reflects the high prevalence of pain in the 
general population3, which is caused by tension, stressful situations or physical demand, 
thereby representing a damaging aspect in people’s quality of life. Abusing analgesics can 
lead to chronic headaches. A study performed in Colombia19 showed that the prevalence 
of headaches due to overuse of analgesics was 4.8%, which is higher than the prevalence 
in developed countries. On the other hand, the analgesic that relieves pain is the same 
one that is used to treat viral febrile, bacterial or inflammatory diseases. Nonsteroidal 
anti-inflammatory drugs (NSAIDS) are also attractive because they act in multiple ways: 
analgesic, antipyretic, and anti-inflammatory. Another aspect that favors and influences 
the consumption of these products is the advertising conveyed in the general media by 
pharmaceutical industry16.
Although the most drugs consumed are non-prescription drugs, it is important not to 
underestimate the possible toxic and adverse effects that might follow in their users. 
Concerning analgesics and (NSAIDS), some of the results worth citing are gastrointestinal 
disorders, allergic reactions and kidney effects14. During a the study by Martinez et al.13 (2014), 
the authors showed that practicing self-medication, among those interviewed, resulted in 
a rate for adverse effects equal to 15.1%; whereas a study by Paula, Bochner and Montilla18 
(2012), which evaluated hospitalizations of the elderly due to intoxication and adverse 
reactions to drugs in Brazil, analgesics, antipyretics and non-opioid antirheumatics were 
responsible for 37.0% of hospitalizations by self-intoxication, occupying the fourth position in 
hospitalizations according to these situations, and were most related to cases of concussion. 
In this study, the place from which the drugs used in the practice of self-medications 
were purchased was not analyzed, but it is likely that the most of them were purchased 
in pharmacies or drugstores or were leftover or from reserve stocks found in pharmacies, 
as was evidenced by at Laste and et al.10 (2012). 
Other limitations of this study are related to the different recall periods employed to 
investigate the use of medications and the possibility of memory bias. This occurs most 
profoundly in the case of using any drugs in the 15 days preceding the interview, and also in 
information given by legal guardians of 15-year-olds with some cognitive disorder or inability 
to answer the questions. The use of some medications may also have underestimated while 
the study was ongoing, such as those that are commonly used, mainly in the South region 
of the country, to treat respiratory problems during winter. 
In conclusion, the Brazilian population, with some regional differences, is no stranger to 
self-medication practice. This practice appears to be influenced by being female, residing in 
the Northeast, Midwest and North regions of Brazil, and by the presence of disease or chronic 
conditions. Most of the drugs consumed do not require prescription, but they are not risk-free, 
meaning that they deserve greater attention from managers and health professionals, as the 
possible intoxication and adverse effects may increase spending on health. Considering 
the aforementioned, regarding the practice of responsible self-medication, encouraged by 
the World Health Organizationa, government investment must largely be used to promote 
sensible use of medication and include strategies for their use in the training of future 
health professionals; these aspects must be a continuous in nature or put in practice by the 
Brazilian Ministry of Health.
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